drugset / Trial / NCT03453151

Abdominal Nerve Blockade in Chronic Heart Failure.

NCT03453151

Phase 1/2 Completed 19 enrolled Duke University
NaSingle-groupOpen-labelTreatment

Summary

Patients with chronic heart failure and undergoing right heart catheterization will be enrolled in this study. Subjects will undergo catheterization of the heart to obtain central cardiac pressure and other cardiac hemodynamic parameters. Subsequently, the subject will undergo a regional nerve block of the splanchnic nerves. This study will be a prospective, uncontrolled clinical trial. The study will not be controlled as invasive monitoring of hemodynamics will be performed, allowing clear demonstration of a cause-effect relationship. The goal of the study is to provide proof of concept. Patients will undergo detailed physiological testing.

Timeline

Start
2018-05-01
Primary completion
2019-06-27
Completion
2019-12-27

Drugs

EvaluationDrugModalityDoseRoute
Background Bupivacaine Other / unclassified
Background Lidocaine Other / unclassified

Indications